MDT•benzinga•
CORRECTION: Medtronic Affirms FY25 Adj EPS Outlook of $5.44-$5.50 vs $5.45 Estimate; Narrows FY25 Sales Guidance from $33.46B-$33.63B To $33.46B-$33.59B vs $33.54B Estimate
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 18, 2025 by benzinga